Stephen Caddick, Wellcome Trust’s Innovations Director, Joins GHIT Fund Council
The Global Health Innovative Technology (GHIT) Fund welcomes Professor Stephen Caddick, PhD, Director of Innovations at the Wellcome Trust, to the Fund’s Council leadership group. As a GHIT Fund Council Member, Prof. Caddick joins leaders from the Government of Japan and the Bill & Melinda Gates Foundation, as well as six Japanese pharmaceutical companies, in providing Board oversight and serving as an advocate for GHIT’s mission.
Prior to assuming his role at Wellcome in June 2015, Prof. Caddick served as Vice Provost (Enterprise & London) and Vernon Professor of Organic Chemistry and Chemical Biology at University College London. He is Co-Founder of Synthetic Pages, an open access website, and Thiologics, an antibody-drug conjugate biotech company. His laboratory focuses on chemical modification of proteins and antibodies for development of therapeutics and diagnostics. He also played an important role in the development of the chemical biology strategy and facilities within the Francis Crick Institute, which was founded by six of the UK's scientific and academic organizations and is the biggest single biomedical laboratory in Europe.
“Stephen Caddick brings rich experience in innovation and dynamic R&D strategy and collaboration to GHIT’s game-changing Council,” said BT Slingsby, CEO and Executive Director of the GHIT Fund. “We are honored to welcome him to our leadership community.”
The Wellcome Trust first partnered with the GHIT Fund as a funder in 2015, investing £3 million in GHIT’s product development pipeline, serving on GHIT’s Selection Committee, and providing an observer to GHIT’s Board of Directors. The Trust is the United Kingdom’s largest provider of non-governmental funding for scientific research and the world's second-largest private funder of medical research.
Learn more about the GHIT Fund’s Council at: https://ghitfund.org/about/governance/council